首页> 外文期刊>Nanomedicine: Nanotechnology, Biology and Medicine >Nanoencapsulation II.Biomedical applications and current status of peptide and protein nanoparticulate delivery systems
【24h】

Nanoencapsulation II.Biomedical applications and current status of peptide and protein nanoparticulate delivery systems

机译:纳米封装II。肽和蛋白质纳米颗粒递送系统的生物医学应用和现状

获取原文
获取原文并翻译 | 示例
       

摘要

The concept of polymeric nanoparticles for the design of new drug delivery systems emerged a few years ago,and recent rapid advances in nanotechnology have offered a wealth of new opportunities for diagnosis and therapy of various diseases.Recent progress has made possible the engineering of nanoparticles to allow the site-specific delivery of drugs and to improve the pharmacokinetic profile of numerous compounds with biomedical applications such as peptide and protein drugs. Biologically active peptides and their analogues are becoming an increasingly important class of drugs.Their use for human and animal treatment is problematic,however,because some of these drugs are generally ineffective when taken orally and thus have been administered chiefly by the parenteral route.This review covers some of the historical and recent advances of nanotechnology and concludes that polymeric nanoparticles show great promise as a tool for the development of peptide drug delivery systems.
机译:高分子纳米颗粒的概念在几年前就出现了,用于设计新的药物递送系统,近来纳米技术的飞速发展为各种疾病的诊断和治疗提供了许多新的机会。最近的进展使得纳米颗粒的工程化成为可能。允许在特定位置递送药物,并改善具有生物医学应用的多种化合物(例如肽和蛋白质药物)的药代动力学特性。具有生物活性的肽及其类似物正成为一类越来越重要的药物。但是,由于某些药物口服时通常无效,因此主要用于肠胃外给药,因此它们在人和动物治疗中的使用存在问题。综述涵盖了纳米技术的一些历史和最新进展,并得出结论,聚合物纳米颗粒作为开发肽药物递送系统的工具显示出巨大的希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号